Fukuda Yasue, Fukuda Koji
General Medical Education and Research Center, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 174-8605, Japan.
School of Political Science and Economics, Waseda University, 1-6-1 Nishi Waseda Shinjyuku-ku, Tokyo, 169-8050, Japan.
BMC Med Ethics. 2018 Nov 21;19(1):91. doi: 10.1186/s12910-018-0330-1.
Children's intentions should be respected. Parents are the key persons involved in decision-making related to their children. In Japan, the appropriate ages and standards for a child's consent and assent, approval, and decision-making are not clearly defined, which makes the process of obtaining consent and assent for clinical research complex. The purpose of this paper is as follows: to understand the attitudes and motives of parents concerning children's participation in medical research and the factors influencing their decision-making. We also sought to clarify who has the right to be involved in decisions regarding children's participation in research.
A semi-structured Internet survey on parents' opinions and attitudes and preferences concerning medical research involvement was conducted. Children were divided into three age groups (6-10-year-olds, 11-14-year-olds, and 15-18-year-olds), with three illness severity categories. Possible correlations between the number of children, children's ages, parents' educational levels, and parents' attitudes were examined.
Among the participants, 42.3% recognized the term "informed consent." The proportion of participants who understood "informed consent" increased with educational level. Four out of five participants did not know, or had not heard of, the term "informed assent." Furthermore, the percentage of those who understood the term "informed assent" increased with academic level. Participants generally believed in prioritizing parents' opinions over children's, and that parents and children would ideally reach a joint decision. Although many parents favored collaborative decision-making, they also wanted their own will reflected in the decision and felt they should receive important information before their children do. Decision-making was affected by the condition's severity and prognosis. This indicates that most Japanese parents believe that their children have the right to know their disease name and treatment; nonetheless, they should be protected. Parents' values and judgments regarding medical intervention involving their children varied.
Children's ability to consent to treatment and research believed to be in their best interests should be assessed appropriately. They should be permitted to provide consent or assent, and their views should be respected. Involving children in decision-making fosters more open communication and transparency between medical professionals, parents, and children.
儿童的意愿应得到尊重。父母是参与与其子女相关决策的关键人物。在日本,儿童同意、赞同、批准和决策的适当年龄及标准并未明确界定,这使得获取临床研究同意和赞同的过程变得复杂。本文的目的如下:了解父母对于儿童参与医学研究的态度和动机以及影响其决策的因素。我们还试图阐明谁有权参与有关儿童参与研究的决策。
开展了一项关于父母对医学研究参与的意见、态度和偏好的半结构化网络调查。儿童被分为三个年龄组(6至10岁、11至14岁和15至18岁),有三种疾病严重程度类别。研究了子女数量、儿童年龄、父母教育水平与父母态度之间可能存在的相关性。
在参与者中,42.3%的人认可“知情同意”这一术语。理解“知情同意”的参与者比例随教育水平的提高而增加。五分之四的参与者不知道或从未听说过“知情赞同”这一术语。此外,理解“知情赞同”这一术语的人的百分比也随学术水平的提高而增加。参与者普遍认为应优先考虑父母而非儿童的意见,并且理想情况下父母和儿童应达成共同决定。尽管许多父母赞成共同决策,但他们也希望自己的意愿能在决策中得到体现,并觉得自己应在孩子之前收到重要信息。决策受病情严重程度和预后的影响。这表明大多数日本父母认为他们的孩子有权知道自己的疾病名称和治疗方法;尽管如此,他们仍应受到保护。父母对于涉及子女的医学干预的价值观和判断各不相同。
应适当评估儿童同意接受被认为符合其最大利益的治疗和研究的能力。应允许他们提供同意或赞同,并且他们的观点应得到尊重。让儿童参与决策可促进医疗专业人员、父母和儿童之间更开放的沟通与透明度。